This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Very Early-Onset Inflammatory Manifestations of X-Linked Chronic Granulomatous Disease.
Frontiers in immunology · 2017
Latest funding
- $1,208,700
Optimizing immunotherapy in high-risk lymphoma
CIHR · 2017 · Principal investigator
1 publications.
Very Early-Onset Inflammatory Manifestations of X-Linked Chronic Granulomatous Disease.
Labrosse R, Abou-Diab J, Blincoe A, Cros G, Luu TM, Deslandres C, Dirks M, Fazilleau L, Ovetchkine P, Teira P, LeDeist F, Fernandez I, Touzot F, Decaluwe H, Halac U, Haddad E
Optimizing immunotherapy in high-risk lymphoma
Principal investigators: Johnson, Nathalie; Decaluwe, Hélène
Keywords: Circulating Tumour Dna; Dlbcl; Follicular Lymphoma; Hodgkin; Immunotherapy; Jak/Stat; Lymphoma; Pd1; Sequencing
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Pediatrics
- Microbiologie et immunologie
- Médecine sociale et préventive
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.